Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

• Main Authors: Chukiat Sirivichayakul (Author), Pornthep Chanthavanich (Author), Kriengsak Limkittikul (Author), Claire-Anne Siegrist (Author), Wassana Wijagkanalan (Author), Pailinrut Chinwangso (Author), Jean Petre (Author), Pham Hong Thai (Author), Mukesh Chauhan (Author), Simonetta Viviani (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: An acellular Pertussis (aP) vaccine containing recombinant genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and Pertactin (PRN) has been developed by BioNet-Asia (BioNet). We present here the results of the first clinical study of this recombinant aP vaccin...